USP25 protein expression was significantly lower in the livers of NAFLD patients than in those of healthy controls, as depicted in Fig. 1A, which was consistent with USP mRNA expression levels reported previously (18). This evidence concerns the gene USP25 and metabolic dysfunction-associated steatotic liver disease.